Clinical Trial Update: A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension [Phase 1]

View source ↗

Summary

Phase I trial evaluating QLS1410 in healthy Chinese adults and individuals with mild essential hypertension; the study status is Not Yet Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• QLS1410

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Uncontrolled Hypertension | Phase 1 | Status: NOT_YET_RECRUITING